These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
162 related items for PubMed ID: 17038919
1. The future challenge in the MELD era: how to match extended-use donors and sick recipients. Ravaioli M, Grazi GL, Ercolani G, Cescon M, Pinna AD, Ballardini G. Transplantation; 2006 Oct 15; 82(7):987-8. PubMed ID: 17038919 [No Abstract] [Full Text] [Related]
2. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft. Yi NJ, Suh KS, Lee HW, Shin WY, Kim J, Kim W, Kim YJ, Yoon JH, Lee HS, Lee KU. Liver Transpl; 2009 May 15; 15(5):496-503. PubMed ID: 19399732 [Abstract] [Full Text] [Related]
3. Donor-recipient MELD-based match in a patient who required three liver grafts in the era of nonstandard donors: case report. Avolio AW, Barbarino R, Siciliano M, Annicchiarico BE, Frongillo F, Agnes S, Castagneto M. Transplant Proc; 2008 May 15; 40(6):2067-9. PubMed ID: 18675132 [Abstract] [Full Text] [Related]
4. Impact of a living donor liver transplant program for hepatocellular carcinoma to the running local deceased donor liver transplant program. Sotiropoulos GC, Malagó M, Molmenti EP, Radtke A, Fouzas I, Beckebaum S, Saner FH, Paul A, Lang H, Broelsch CE. Dig Dis Sci; 2010 Mar 15; 55(3):872-3. PubMed ID: 19294504 [No Abstract] [Full Text] [Related]
5. Should we expand the criteria for liver transplantation for hepatocellular carcinoma--yes, of course! Broelsch CE, Frilling A, Malago M. J Hepatol; 2005 Oct 15; 43(4):569-73. PubMed ID: 16120470 [No Abstract] [Full Text] [Related]
6. Should we expand the criteria for hepatocellular carcinoma with living-donor liver transplantation?--no, never. Hiatt JR, Carmody IC, Busuttil RW. J Hepatol; 2005 Oct 15; 43(4):573-7. PubMed ID: 16112768 [No Abstract] [Full Text] [Related]
7. Liver transplantation using donors older than 80 years: a single-center experience. Petridis I, Gruttadauria S, Nadalin S, Viganò J, di Francesco F, Pietrosi G, Fili' D, Montalbano M, D'Antoni A, Volpes R, Arcadipane A, Vizzini G, Gridelli B. Transplant Proc; 2008 Oct 15; 40(6):1976-8. PubMed ID: 18675105 [Abstract] [Full Text] [Related]
8. Liver transplantation for hepatocellular carcinoma: how far can we push the envelope? Tan KC. Singapore Med J; 2003 Jun 15; 44(6):309-11. PubMed ID: 14560865 [No Abstract] [Full Text] [Related]
9. Liver transplantation: an update 2008. Said A, Lucey MR. Curr Opin Gastroenterol; 2008 May 15; 24(3):339-45. PubMed ID: 18408462 [Abstract] [Full Text] [Related]
10. Editorial on "a revised scoring system utilizing serum alphafetoprotein levels to expand candidates for living donor liver transplantation in hepatocellular carcinoma". Lo CM. Surgery; 2007 Jul 15; 142(1):119-20. PubMed ID: 17630008 [No Abstract] [Full Text] [Related]
11. Impact of model for end-stage liver disease on patient survival and disease-free survival in patients receiving liver transplantation for hepatocellular carcinoma. Moonka D, Castillo E, Kumer S, Abouljoud M, Divine G, Pelletier S. Transplant Proc; 2009 Jul 15; 41(1):216-8. PubMed ID: 19249517 [Abstract] [Full Text] [Related]
12. A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. Piscaglia F, Camaggi V, Ravaioli M, Grazi GL, Zanello M, Leoni S, Ballardini G, Cavrini G, Pinna AD, Bolondi L. Liver Transpl; 2007 Jun 15; 13(6):857-66. PubMed ID: 17539006 [Abstract] [Full Text] [Related]
13. Current status and issues of living donor liver transplantation for hepatocellular carcinoma. Tanaka K, Yamada T. Chir Ital; 2005 Jun 15; 57(2):137-43. PubMed ID: 15916138 [No Abstract] [Full Text] [Related]
14. Selection criteria for patients with hepatocellular carcinoma in liver transplantation. Kaido T, Takada Y, Uemoto S. Transplantation; 2009 Aug 15; 88(3):442-3; author reply 443. PubMed ID: 19667951 [No Abstract] [Full Text] [Related]
15. Selection of HCC patients for liver transplantation: the Milan criteria, Hangzhou criteria and beyond. Fan ST. Hepatobiliary Pancreat Dis Int; 2008 Jun 15; 7(3):233-4. PubMed ID: 18522876 [No Abstract] [Full Text] [Related]
16. A decade of right liver adult-to-adult living donor liver transplantation: the recipient mid-term outcomes. Chan SC, Fan ST, Lo CM, Liu CL, Wei WI, Chik BH, Wong J. Ann Surg; 2008 Sep 15; 248(3):411-9. PubMed ID: 18791361 [Abstract] [Full Text] [Related]
17. Liver transplantation at UCSF--a 20-year experience. Hirose R, Yao F, Stock P, Roberts J, Ascher N. Clin Transpl; 2008 Sep 15; ():119-25. PubMed ID: 19708450 [Abstract] [Full Text] [Related]
18. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database. Jakab SS, Navarro VJ, Colombe BW, Daskalakis C, Herrine SK, Rossi S. Liver Transpl; 2007 Oct 15; 13(10):1405-13. PubMed ID: 17902126 [Abstract] [Full Text] [Related]
19. Living donor liver transplantation for recurrent hepatocellular carcinoma. Liu C, Frilling A, Sotiropoulos GC, Weber F, Nadalin S, Malago M, Broelsch CE. Transpl Int; 2005 Jul 15; 18(7):889. PubMed ID: 15948872 [No Abstract] [Full Text] [Related]
20. Living donor liver transplantation for hepatocellular carcinoma: Tokyo University series. Sugawara Y, Tamura S, Makuuchi M. Dig Dis; 2007 Jul 15; 25(4):310-2. PubMed ID: 17960065 [Abstract] [Full Text] [Related] Page: [Next] [New Search]